Revance raises $25 million

Revance Therapeutics Inc. (Newark, Calif.) raised $25 million in a first close of a planned $35 million series D round led by existing investor Essex Woodlands Health Ventures. Existing investors Vivo Ventures; Technology Partners; Shepherd Ventures; Palo Alto Investors; BioOne Capital; and Pac-Link Ventures also participated. Revance expects to complete a $10 million second close with new investors in about 90 days. ...